Showing results (61-70 of 90) with videos related to
Sort By:
Pageof 9
Biochemical and Biophysical Research Communications|July 16, 2014
AS-2, a novel inhibitor of p53-dependent apoptosis, prevents apoptotic mitochondrial dysfunction in a transcription-independent manner and protects mice from a lethal dose of ionizing radiationAkinori Morita, Shinya Ariyasu, Bing Wang, et al.Genes to Cells : Devoted to Molecular & Cellular Mechanisms|February 1, 2008
Peptidoglycan and lipopolysaccharide activate PLCgamma2, leading to enhanced cytokine production in macrophages and dendritic cellsDaisuke Aki, Yasumasa Minoda, Hideyuki Yoshida, et al.Radiation Research|April 19, 2012
A modified system for analyzing ionizing radiation-induced chromosome abnormalitiesLin Shi, Kurumi Fujioka, Jiying Sun, et al.Journal of Radiation Research|March 31, 2006
Nuclear abnormalities in aspirated thyroid cells and chromosome aberrations in lymphocytes of residents near the Semipalatinsk nuclear test siteNobuo Takeichi, Masaharu Hoshi, Shozo Iida, et al.The Journal of Biological Chemistry|November 6, 2009
Up-regulation of survivin by the E2A-HLF chimera is indispensable for the survival of t(17;19)-positive leukemia cellsMayuko Okuya, Hidemitsu Kurosawa, Jiro Kikuchi, et al.Blood|January 25, 2005
TEF, an antiapoptotic bZIP transcription factor related to the oncogenic E2A-HLF chimera, inhibits cell growth by down-regulating expression of the common beta chain of cytokine receptorsTakeshi Inukai, Toshiya Inaba, Jinjun Dang, et al.British Journal of Haematology|August 16, 2023
Tumour-derived exosomes promote the induction of monocytic myeloid-derived suppressor cells from peripheral blood mononuclear cells by delivering miR-106a-5p and miR-146a-5p in multiple myelomaKentaro Mizuhara, Yuji Shimura, Taku Tsukamoto, et al.Nucleic Acids Research|March 15, 2014
Novel functional small RNAs are selectively loaded onto mammalian Ago1Natsuko Yamakawa, Kazuki Okuyama, Jun Ogata, et al.Life (Basel, Switzerland)|October 23, 2021
A Novel RNA Synthesis Inhibitor, STK160830, Has Negligible DNA-Intercalating Activity for Triggering A p53 Response, and Can Inhibit p53-Dependent ApoptosisAkinori Morita, Shintaro Ochi, Hidetoshi Satoh, et al.Leukemia Research|October 27, 2012
Diverse underlying proliferation response to growth factors in imatinib-treated Philadelphia chromosome-positive leukemiasAtsushi Nemoto, Takeshi Inukai, Kanako Uno, et al.Pageof 9